Vaccination of susceptible animals against foot and mouth disease (FMD) is a proven strategy for helping to combat the disease since the virus is highly infectious and can be spread by infected animals. FMD is caused by seven different types of serotypes: O, A, C, Asia 1 and Southern African Territories (SAT) 1, 2 and 3. The major symptoms of FMD are high fever, sudden weight loss, increased death rate in newborn animals, low conception rate, painful lesions in and around mouth, lips and feet, and excessive salivation. Cloven-hoofed animals especially cattle, pigs, sheep and goats are susceptible to FMD. The FMD vaccines traditionally represents the largest share of the veterinary vaccine market worldwide in terms of sales of the entire livestock biological business.
The global foot and mouth disease vaccine market report estimates the market size (Revenue US$ million – 2014 to 2021) and composition of this market and also forecasts growth trends (CAGR% – 2017 to 2021). It also covers the major companies operating in the market and provides detailed market analysis of the different animal types (cattle, pigs, sheep and goats, others) and FMD vaccine types (conventional – Al(OH)3-based and oil-based, and emergency vaccines) available in the global market.
The global foot and mouth disease vaccine market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global foot and mouth disease vaccine market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global foot and mouth disease vaccine market and included in this report are Agrovet Co., Bayer AG, Biogenesis Bagó, Brilliant Bio Pharma Limited, Indian Immunologicals Ltd., Inova Biotechnologia, Intervac (Pvt.) Ltd., Merial, and Merck Animal Health (MSD).